© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Escitalopram oxalate comes from a long pursuit to create better antidepressants that balance results with fewer side effects. Back in the late 1990s, scientists searched for the purest components of racemic citalopram, hoping that isolating just the S-enantiomer would trim down side effects and amp up the results. Clinical research teams across Europe and North America teamed up, bringing experience from different backgrounds. Some of these folks saw how broader, less-targeted drugs left people with dry mouth, sexual problems, and dizziness. Drawing from their frustration and hope for something better, the work rapidly shifted toward making escitalopram standard practice. Patents started building up, leading to regulatory approvals throughout the early 2000s. Personal stories echo in that history: psychiatrists saw some of their most withdrawn patients re-engage with daily life, parents regained lost family moments, and pharmacists watched a medication once new become part of routine practice. Decades of incremental progress came together in a medicine now prescribed by general practitioners and specialists alike.
Looking at it on the shelf, escitalopram oxalate doesn’t stand out visually. The package reads like many others: little oval tablets in white or pale-yellow, usually encased in foil strips or stashed in plastic bottles, marked in straightforward language. The content typically sits at 5, 10, or 20 milligrams per tablet, a range chosen so clinicians can tailor adjustments without needless complexity. Pharmacies recognize dozens of generic and branded forms, such as Lexapro, Cipralex, and countless regional names. The World Health Organization’s Model List of Essential Medicines lists escitalopram, reflecting not only its widespread impact but a strong trust in its balance of cost and result. The daily presence of escitalopram in community clinics and large hospital systems signals a product that thousands rely on for mood stability and relief from anxiety.
Escitalopram oxalate solidifies as a white to off-white powder, fitting comfortably into many blending and formulation workflows. Chemically, it draws attention for being the S-enantiomer of citalopram, focusing on serotonin uptake inhibition with less interaction elsewhere. Its formula, C20H21FN2O•C2H2O4, lets researchers keep the product stable, but they watch moisture and light exposure since it breaks down with too much humidity or heat. The melting point falls near 146-149°C, normal for tablets needing to resist breakdown through packaging and storage mishaps. In water, it dissolves at a level that pharmaceutical engineers can work with during compounding, but solubility shifts fast if pH swings too far from neutral. These properties aren’t just chemistry, they affect how reliably a pharmacy can keep stock usable and whether a patient’s dose will stay consistent.
Manufacturers present dense technical specifications with every batch, often translating years of batch trouble into fine print. Labeling points out the drug strength in clear numbers, includes warnings about suicidality risk in teens and young adults, and contains a long list of excipients that keep the drug flowing and compressible. Each lot must test pure, showing less than 0.5% related substances depending on regulatory standards. The moisture content has to sit below tight thresholds—excess humidity ruins shelf life and reliability. Pharmacopeia references dictate tests like high-performance liquid chromatography to verify dose and uniformity. Labels include the drug’s chemical name, dosing information, instructions for missed doses, and keep-out-of-reach statements. These measures anchor patient safety, drawing on years of mistakes and recalls that taught manufacturers never to leave loose ends in documentation.
Chemists usually start with 1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile as a key raw material, using enantioselective synthesis steps or chiral resolution to focus only on the S-enantiomer. Typical methods blend classical organic transformations with modern catalyst-assisted tricks to trim down yield loss and unwanted isomers. For large-scale batches, manufacturers add oxalic acid during the final purification, ensuring product crystallization in oxalate form for stability and shelf life. Talented process chemists learn from trial and error: They swap out solvents, filter out fragments, and keep one eye on waste streams that environmental regulators will soon inspect. The best facilities can track each intermediate, providing full traceability so later quality audits don’t return costly surprises. Most pharmaceutical labs work to cut down solvent waste or find greener reagents with each production cycle, a quiet sign of science’s constant push to reuse and reduce.
At the heart of this molecule’s origin, researchers hone in on an asymmetric synthesis or resolution from the racemic mix. Catalytic hydrogenation, selective crystallizations, and salt formation with oxalic acid form the main steps. There’s always a risk during these reactions that heat or reagents might trigger unwanted impurities, so skilled technicians monitor temperature, pressure, and pH with persistence. Some research teams experiment by attaching different salt forms or adding short alkyl chains to probe changes in absorption, side effect profile, or shelf stability. Many of these modifications only reach the bench, but a handful eventually kickstart further research into sister drugs with even more serotonin selectivity or shifted receptor activity. This molecule’s story mirrors broader trends as chemists chase single-isomer drugs, always looking for that step forward in patient relief.
Escitalopram oxalate goes by many names, partly from patent layering and partly for branding grabs. The core chemical is S-citalopram oxalate, with synonyms including (+)-escitalopram oxalate and (S)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile oxalate. In the clinic, most patients recognize it as Lexapro or Cipralex, depending on the pharmacy’s supplier. Generics use names designed to meet regulatory scaffolding, sometimes with “escitalopram oxalate tablets USP” or similar tags. Language changes by country, but the focus stays the same: a single, reliable version of a core antidepressant. Health professionals nearly always rely on brand or simple generic terms. Complex synonyms live in the supply and regulatory chain, rarely reaching beyond specialists or auditors.
Strict safety standards surround manufacturing and handling. Production centers maintain dust control, proper ventilation, and closed-system transfers. Technicians wear gloves, eye shields, and carry out skin protection whether handling raw powder or compressed tablets. Product storage lines require dry, cool conditions and tamper-evident packaging, helping catch any break in temperature or humidity tracking. In clinical use, black box warnings notify about suicidal thinking risk in adolescents and young adults, driving policies for regular follow-up after prescription starts. Hospitals maintain narcotics-style logs for high-dose stocks, wary of misuse despite low potential compared to controlled substances. Cleanup after spills involves stepwise dilution, neutralization, and documentation, driven by warnings over possible skin or eye irritation. Safety data sheets detail first aid, accidental exposure, fire-fighting methods, and proper waste disposal, upholding high standards earned from earlier mishaps that harmed staff health or interrupted operations.
Doctors across psychiatry, internal medicine, and primary care turn to escitalopram oxalate often as a first-line treatment for major depressive disorder and generalized anxiety disorder. It also finds use against panic disorder, obsessive-compulsive disorder, and certain off-label problems like social anxiety. Patients range from teenagers struggling through exams to retirees facing life transitions. The drug’s slow, gentle start means titration becomes habit for many clinicians, starting low and moving up as needed to control symptoms. Community mental health clinics keep it stocked for walk-in crisis care, while telehealth platforms increasingly distribute it under remote monitoring. Payers and policy teams list it high on formularies for both cost savings and trusted results, supporting long-term use for those with chronic mood struggles.
Research teams keep investigating escitalopram, fueled by patient stories and market needs. Clinical data supports use in combination therapy—stacked with counseling or augmentation by other pharmacological agents for treatment-resistant cases. Bioequivalence trials let new generics reach the market after patents expire, supporting more affordable access. Drug metabolism research digs into interactions with CYP enzymes, guiding clinicians on what to avoid or carefully monitor if a patient needs more than one medication. At the same time, teams collect real-world data on side effects, adverse events, and long-term outcomes, helping ensure benefit-risk tradeoffs remain transparent. Most recently, digital health studies track adherence and symptom control through phone apps, trying to fill gaps in follow-up that once left patients struggling in silence. Each new trial, registry, or data set tightens the safety net, cementing this compound as more than just a pill, but a foundation of mental health care for millions.
Toxicology teams monitor acute and chronic exposure in detail. Animal models help establish safe ranges, pushing doses well above the norm to map out what organs risk damage under abuse or accidental swallowing. Liver, kidney, and central nervous system impacts top the list during both regulatory submissions and post-market research. Most overdose cases present with drowsiness, dizziness, and minor changes in heart rhythm, but fatalities remain rare and usually tie to polypharmacy. Emergency rooms document trends, occasionally flagging abnormal heart rhythms, which led to the black box warning on QT prolongation risk—especially when combined with other drugs that slow down the heart’s electrical reset. Human data keeps growing, yet the focus remains on continuous education for prescribers to catch and safely manage the handful of serious toxic events that surface each year. Reports and registries aim to keep every stakeholder aware of risks, so patients feel informed rather than blindsided.
Looking ahead, escitalopram oxalate stands as a benchmark for what targeted antidepressants can deliver, but future versions may bring further upsides. Medicinal chemists work on tweaking the scaffold to rebalance side effects or stretch benefits to new disease states like chronic pain or even some types of neurodevelopmental conditions. Reformulation teams tinker with extended-release or rapid-onset versions, aiming to match individual lifestyle and symptom needs. Digital health platforms look for smarter ways to connect prescription and follow-up, closing the gap between the clinic and home for patients who feel isolated or overwhelmed. Pricing debates roll on, as governments and advocacy groups argue for wider access without losing manufacturing quality. The next decade may see genetic screening help clinicians tailor dosing, hoping to guide more people to relief without weeks of trial and error. From my time listening to both patients and clinicians, there’s a sense that progress blends slow, steady improvement with occasional big leaps—escitalopram today shows how much can change when relentless curiosity meets compassion and science.
Many people struggle with depression and anxiety. Doctors often prescribe medications to help manage symptoms so patients can start feeling like themselves again. Escitalopram Oxalate, sold under the brand name Lexapro among others, is one of these medications. It belongs to a group of drugs called selective serotonin reuptake inhibitors, or SSRIs. These medicines support brain chemistry by helping increase serotonin, a neurotransmitter involved in mood regulation.
Research over several decades continues to show that serotonin plays a key role in mental health. Low levels have been linked to depression and anxiety disorders. By preventing the body from rapidly reabsorbing serotonin, Escitalopram Oxalate helps keep this chemical active in the brain for longer. As a result, it brings some people welcome relief from persistent sadness, worry, and nervousness.
A lot of folks feel awkward reaching out for help with their mental health. It can be tough to admit things aren’t going well. I remember a friend struggling to function during a college semester, falling behind in classes and pulling away socially. The stigma around medication kept him from accepting help at first. Once he started Escitalopram Oxalate, he found it easier to cope—days grew less heavy, and motivation returned bit by bit. His story matches what clinical trials show: for many people, this medication can lift symptoms enough so they can focus on therapy, school, work, and relationships.
Escitalopram Oxalate is not just for depression. Doctors also prescribe it for generalized anxiety disorder. This diagnosis covers people who spend most days feeling on edge, restless, or unable to switch off racing thoughts. It’s common for anxious feelings to turn physical — tight chest, clenched jaw, trouble sleeping. Data from the National Institute of Mental Health points to millions of Americans living with these problems long-term. Quality of life decreases, and basic tasks take far more effort. Medication like Escitalopram Oxalate offers another tool, sometimes alongside therapy or lifestyle changes.
People want to know what to expect, both the positives and the potential drawbacks. No medicine is perfect. Some people notice side effects like nausea, headaches, or trouble sleeping. A smaller group may have changes in appetite, libido, or experience increased anxiety early on. It takes about two to four weeks for most people to see full improvement in mood or anxiety, which calls for patience and close follow-up visits.
Children, teens, and young adults seem more susceptible to rare but serious risks like increased thoughts of self-harm, so doctors monitor closely. Regular check-ins help make sure progress continues and catch any early warning signs. For adults dealing with major depression or anxiety, most studies point to lasting improvements with judgment and ongoing medical supervision.
Treatment always works best as a partnership—open conversation between patients and healthcare providers matters. If side effects crop up, adjustments like dose changes or adding talk therapy make a difference. Relying on medication alone doesn’t solve every problem, but for many, it builds a foundation to be more present and engaged in life. Backed by years of research and millions of prescriptions, Escitalopram Oxalate stands as an important option in treating mental health conditions, especially when paired with ongoing care, lifestyle tweaks, and trusted support networks.
Doctors reach for escitalopram oxalate, better known as Lexapro, when depression and anxiety overwhelm daily life. From talking with people who actually take it, I’ve noticed most don’t start the journey lightly. They want their days to get easier, not harder. No one wants to trade miserable symptoms for a new set they can’t control. Still, the relief often outweighs the hassle once folks settle into their medication routines.
Escitalopram tweaks the brain’s serotonin—a chemical that steers mood, sleep, and appetite. That chemical shift triggers a range of side effects. Most common: people mention dry mouth. You end up carrying a water bottle everywhere and chewing gum like it’s your new hobby. Trouble sleeping often pops up. For some, it feels like lying in bed with a head full of static.
Appetite changes crop up, too. Some skip meals because food loses its appeal, while others graze all day. I’ve noticed friends complain about feeling tired, even after sleeping more. Others talk about headaches or dizziness, which can mess with work and social plans. Then there’s the stomach: queasiness, sometimes diarrhea, sometimes constipation—nobody seems eager to share these details, but they matter.
Sexual side effects often surprise new patients. They’d rather not talk about it, yet plenty report issues: lower libido, trouble reaching climax. These symptoms cause frustration and impact relationships. Some folks develop excessive sweating—heavy enough that it pushes them to swap shirts midday. Occasionally, shaking or feeling restless sneaks up, making hands jitter, or legs fidget under the desk.
Clinical trials and patient surveys back up these real-world stories. The U.S. National Library of Medicine lists side effect rates: over 10% of users experience nausea, over 10% feel sleepy, and about 8% deal with trouble sleeping. Sexual side effects show up in over 6% of users. Dry mouth and increased sweating affect a fair share. Data paints the same picture you hear from people in clinics and support groups.
These symptoms aren’t just side notes—they shape how people stick with treatment. A friend of mine stopped medication after constant nausea. Another kept at it after talking with her provider, adjusting her dose, and adding more balanced meals. Professional advice goes a long way, but unless patients speak up, those conversations don’t happen. Doctors must listen without judgment, and patients should feel safe asking about any symptom, not just the “serious” ones.
For anyone weighing escitalopram, it helps to remember most side effects appear early. Many fade after a few weeks. Open conversations make all the difference, especially since untreated depression and anxiety take such a heavy toll if left alone.
Anyone struggling through side effects stands to benefit from honest tracking. Writing down symptoms in a notebook or an app helps spot patterns. Drinking more water, eating regularly, and getting outside for light exercise lay a good foundation. If something gets unbearable—like intense sadness, dark thoughts, or allergic signs—call your provider right away.
Doctors may adjust the dose, switch brands, or suggest timing medication differently, like taking it at night if daytime drowsiness disrupts life. Extra support from therapy or peer groups can help smooth the transition. In the end, real-life feedback—shared openly with trusted healthcare professionals—keeps people safer and closer to the kind of life they’re trying to reclaim.
Feeling anxious, weighed down by depression, or both, puts life on pause. Escitalopram Oxalate gives many people a chance to get moving again. Doctors often choose this medication because of its reliable track record for treating these conditions. For most, starting this medicine comes with questions. I remember staring at a new prescription and feeling half-hopeful, half-nervous. No one wants to fumble through something that’s supposed to help.
Doctors usually tell their patients to take Escitalopram Oxalate at the same time each day. Swallow the pill whole with water—avoid chewing or crushing it. Consistency makes a real difference. I found that taking it after breakfast kept my routine solid, and it cut down the chance of stomach upset. Some get advice to take it at bedtime if they feel drowsy. What matters? Pick a time that fits your schedule and stick to it.
Missing a dose is common. I’ve forgotten now and then. If it’s been just a few hours, I’d take the missed tablet that day. Further into the day, skip it and don’t double up. Too much of this medicine can cause trouble, like nausea, sweating, or feeling jittery. Keep an eye on the dosing schedule, but don’t panic from one error.
While starting Escitalopram, patience gets tested. It may take two to four weeks to notice changes. Putting too much hope into overnight transformation leads to disappointment. I learned that slow progress still counts. Feeling worse before feeling better sometimes happens. This doesn’t mean the medicine isn’t working.
Common side effects include dry mouth, headaches, or gastrointestinal upset. I experienced a few days of restlessness. These effects often fade. Serious issues like severe mood changes, trouble breathing, or muscle twitching require medical attention. Checking in with your healthcare provider after a few weeks helps spot any concerns early, and adjustments can be made as needed.
Using this medicine works best with honest communication. Let your doctor know about other prescriptions, supplements, or even herbal products you take. Some medicines, like certain painkillers and migraine drugs, can’t mix with Escitalopram safely. Alcohol can increase sedation and isn’t a good match. I avoided it, even at social events, and found that friends who knew the reason respected my choice.
Lifestyle helps too. A good walk, small routines, and steady sleep patterns support recovery alongside Escitalopram. These may sound basic, but I noticed the lifting of everyday stress after following this advice. Nutrition and hydration play a role as well. There’s no magic fix, yet combining these habits with the medication makes a difference.
Taking Escitalopram Oxalate forms part of a bigger picture. Mental health deserves respect and attention, just as physical health does. People shouldn’t shy away from asking questions at their appointments. Track changes or side effects and share them. Sometimes, the dose needs tweaking or even switching medications.
Open dialogue, reliable habits, and patience help this medication work the way it’s supposed to, supporting a path back to balance. I’ve seen that small steps during treatment make the biggest impact over time.
Most people don’t just take one medication these days. A morning routine can include pills for high blood pressure, heartburn, cholesterol, or allergies — and for some, Escitalopram Oxalate for anxiety or depression. Doctors prescribe it under brand names like Lexapro, as part of treatment for depression and generalized anxiety disorder. It’s common for folks to wonder: “Can I take this with the rest of my meds?”
Taking several medications can lead to serious problems, even if each one is helpful alone. With Escitalopram Oxalate, the big concern is drug interactions. Some combinations can cause side effects ranging from sleepiness to dangerous heart rhythms. Other drugs boost the risk of serotonin syndrome, which can cause tremors, fever, confusion, or even seizures.
Doctors look out for medications that change how Escitalopram works in the body. For example, other antidepressants, certain painkillers, migraine drugs, antibiotics like linezolid, or even herbal products like St. John’s Wort can all interact. Blood thinners such as warfarin or aspirin add a bleeding risk. Mixing up even simple over-the-counter pills isn’t always safe — for example, some cold medicines.
It’s easy to think of a prescription as a fix. From experience working with patients, I’ve seen folks pick up new medications for joint pain or indigestion without thinking about the ones they already take. Adding a new medication like Escitalopram may seem routine, but it’s anything but simple. Data from the CDC show that over 20% of adults use five or more prescription drugs. The chances of a dangerous mix-up go up with each new bottle in the bathroom cabinet.
Even pharmacists can miss potential problems if a patient uses more than one pharmacy, or skips listing a supplement at the doctor’s office. It isn’t just up to professionals in the clinic. Patients have a say in protecting themselves. It takes good communication and honesty, and that means bringing out every pill bottle at your checkup, not just the ones with your name from your main doctor.
Consider a patient I worked with who felt tired and dizzy after starting Lexapro. After digging around, we figured out she’d recently started using an allergy medication available at every supermarket — diphenhydramine. The combination slowed her down more than either drug alone. More serious cases show up, too. Emergency rooms see people every day who feel shaky or confused because of a stack of medications that didn’t play well together.
Making a list of every pill, vitamin, or supplement and sharing it with your health team makes a huge difference. Doctors rely on what patients tell them. Pharmacists can double-check for conflicts if they see a full list. The more honest and detailed you are, the safer your treatment becomes. Technology helps, too. Electronic medical records flag certain interactions, but these alert systems only help if they have the truth in front of them.
There’s value in asking questions. If a new medication comes up, speaking up for yourself — “Is this safe with what I already use?” — isn’t just smart, it’s essential. Safety comes from teamwork between patient and provider. Mixing medications is more common than ever, but a cautious approach and open conversation keep risks in check.
Starting escitalopram oxalate often means wrestling with hope and doubt. I remember sitting in a doctor’s office, listening to a quiet explanation about this little pill and what it promised. My doctor said the word “weeks” more than once, and I left both relieved and frustrated.
Many expect to feel better in a few days. The brain runs on chemical messengers called neurotransmitters, and escitalopram helps keep one called serotonin hanging around longer. This shift doesn’t happen overnight. For lots of folks, the first week or two brings more side effects than relief. Headaches, sleepiness, a dry mouth—that’s what hung around my days at first. No sign of the mood or anxiety shift yet.
Doctors often point to the 2-4 week mark as the window when positive changes might start. I checked calendars and tried to count how many mornings had passed after my first dose. Some research agrees that patients need at least two weeks to feel mood changes, but real improvement usually grows across 4-6 weeks. For some, it takes up to eight. The slow timeline comes from the way brain cells build new habits and rewire signals, which can’t be rushed by swallowing extra pills or drinking more water. I didn’t wake up with a light bulb moment. Instead, life over a month started to feel less heavy.
Not everyone travels through the same timeline. The dose makes a difference. Some begin at the standard 10 mg, but might need adjustments if side effects bite hard or changes feel too slow. Age, overall health, and severity of symptoms also play major roles. Stress at work, unpredictable sleep, or other medicine won’t help the process run smoothly. For me, keeping up my daily walks and sticking to a bedtime routine made the wait a little easier, though there were nights I doubted anything would work.
It’s easy to feel impatient when nothing seems to change. Friends may ask if the new medicine works. Sometimes, all you can say is, “Not yet.” That’s normal. If four weeks pass and you feel nothing at all, doctors say it’s okay to start asking tough questions about whether to raise the dose or try a different approach. No one should stop suddenly or mix escitalopram with new supplements without checking with a pharmacist or prescriber. Stopping cold can bring on headaches, dizziness, or a big drop in mood. These are real risks—places where expert advice matters more than an internet search or guesswork.
Trying out medicine like escitalopram is an act of trust. Few journeys to better mental health run smooth or short. If the waiting grows hard, sharing updates with your healthcare team helps. Keeping a simple mood journal showed me the small wins I might have missed. Talking—honestly and regularly—made me feel heard, and sometimes even hopeful.
Treatment works best with more than just a pill. Therapy or support groups can fill the gaps that medicine leaves behind. No one has to wait alone. If days get darker or new symptoms pop up, reaching for help—not just toughing it out—turns out to be the stronger move.
| Names | |
| Preferred IUPAC name | (1S)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile; oxalic acid |
| Other names |
Escitalopram Lexapro Cipralex S-Citalopram |
| Pronunciation | /ɛkˌsaɪtəˈloʊpræm ˈɒksəˌleɪt/ |
| Identifiers | |
| CAS Number | 219861-08-2 |
| Beilstein Reference | 3441735 |
| ChEBI | CHEBI:63638 |
| ChEMBL | CHEMBL1425 |
| ChemSpider | 133089 |
| DrugBank | DB01175 |
| ECHA InfoCard | 100.224.943 |
| EC Number | EC 3.2.1.4 |
| Gmelin Reference | 8771893 |
| KEGG | D08941 |
| MeSH | D000068879 |
| PubChem CID | 60756 |
| RTECS number | YQ16NW3FZP |
| UNII | OXG135ZX8L |
| UN number | UN3249 |
| Properties | |
| Chemical formula | C20H21FN2O•C2H2O4 |
| Molar mass | 414.43 g/mol |
| Appearance | White to off-white powder |
| Odor | Odorless |
| Density | 1.2 g/cm³ |
| Solubility in water | Freely soluble in water |
| log P | 2.2 |
| Vapor pressure | 7.3E-12 mmHg at 25°C |
| Acidity (pKa) | 9.84 |
| Basicity (pKb) | 7.2 |
| Magnetic susceptibility (χ) | Magnetic susceptibility (χ): -77.9×10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.56 |
| Viscosity | Viscous liquid |
| Dipole moment | 3.01 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 354.2 J·mol⁻¹·K⁻¹ |
| Pharmacology | |
| ATC code | N06AB10 |
| Hazards | |
| Main hazards | May cause allergic reactions, drowsiness, dizziness, suicidal thoughts, or serotonin syndrome. |
| GHS labelling | GHS07, GHS08, Warning, H302, H315, H319, H335, H361, P261, P264, P271, P280, P302+P352, P305+P351+P338, P405, P501 |
| Pictograms | 💊⚠️🚗🍷🚫🤰📵 |
| Signal word | No signal word |
| Hazard statements | Hazard statements: Harmful if swallowed. Causes serious eye irritation. May cause respiratory irritation. |
| Precautionary statements | Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. Store at controlled room temperature, 20°-25°C (68°-77°F). Protect from moisture. Dispense in a tight, light-resistant container. |
| Flash point | > 230 °C |
| Autoignition temperature | 510 °C |
| Lethal dose or concentration | LD50 (oral, rat): 155 mg/kg |
| LD50 (median dose) | 2050 mg/kg (rat, oral) |
| NIOSH | Not Listed |
| PEL (Permissible) | Not established |
| REL (Recommended) | 10 mg/tablet |
| Related compounds | |
| Related compounds |
Citalopram Desmethylcitalopram Racemic citalopram Escitalopram Citalopram hydrobromide |
